This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.
The costs and outcomes of paediatric tuberculosis treatment at primary healthcare clinics in Johannesburg, South Africa E P Budgell,1 MSc; D Evans,1 PhD; R Leuner,1 MCom; L Long,1,2 PhD; S Rosen,1,2 MPA H ealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa 2 Department of Global Health, School of Public Health, Boston University, USA 1
Corresponding author: D Evans ([email protected]
) Background. Little up-to-date information is available about the costs of providing drug-susceptible tuberculosis (DS-TB) treatment to paediatric patients in South Africa (SA), nor have actual costs incurred at clinics been compared with costs expected from guidelines. Objectives. To estimate actual and guideline treatment costs by means of a retrospective cohort analysis. Methods. We report patient characteristics, outcomes and treatment costs from a retrospective cohort of paediatric and adolescent (